Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41416-020-01246-0 http://scihub22266oqcxt.onion/10.1038/s41416-020-01246-0 33531686!8039039!33531686     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33531686&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Br+J+Cancer 2021 ; 124 (8): 1344-1345 Nephropedia Template TP {{tp|p=33531686|t=2021. More light on cancer and COVID-19 reciprocal interaction |pdf=|usr=}}{{33531686}} gab.com Text More light on cancer and COVID-19 reciprocal interaction JO: Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33531686 #FOAvip Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing, the SARS-CoV-2 target. Twit Text FOAVip More light on cancer and COVID-19 reciprocal interaction ????Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33531686 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33531686 #FOAvip English Wikipedia <ref>{{Cite pmid|33531686}}</ref> More light on cancer and COVID-19 reciprocal interaction #MMPMID33531686 Brest P; Mograbi B; Hofman P; Milano G Br J Cancer 2021[Apr]; 124 (8): 1344-1345 PMID33531686show ga Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing, the SARS-CoV-2 target. |ADAM17 Protein/*genetics[MESH] |Angiotensin-Converting Enzyme 2/genetics[MESH] |COVID-19/complications/epidemiology/*genetics/virology[MESH] |Humans[MESH] |Mortality[MESH] |Neoplasms/complications/epidemiology/*genetics/virology[MESH] |SARS-CoV-2/genetics/pathogenicity[MESH]More light on cancer and COVID-19 reciprocal interaction (epmc).pdf DeepDyve Pubget Overpricing